[1]
|
徐勇, 王军, 王虹峥, 等. 2023中国阿尔茨海默病数据与防控策略[J]. 阿尔茨海默病及相关病, 2023, 6(3): 175-192.
|
[2]
|
Abdelmaksoud, N.M., Sallam, A.M., Abulsoud, A.I., et al. (2024) Unraveling the Role of MiRNAs in the Diagnosis, Progression, and Therapeutic Intervention of Alzheimer’s Disease. Pathology: Research and Practice, 253, Article ID: 155007. https://doi.org/10.1016/j.prp.2023.155007
|
[3]
|
Liu, S., Fan, M., Zheng, Q., et al. (2022) MicroRNAs in Alzheimer’s Disease: Potential Diagnostic Markers and Therapeutic Targets. Biomedicine & Pharmacotherapy, 148, Article ID: 112681. https://doi.org/10.1016/j.biopha.2022.112681
|
[4]
|
Zhang, H., Liu, W., Ge, H., et al. (2021) Aberrant Expression of MiR-148a-3p in Alzheimer’s Disease and Its Protective Role against Amyloid-β Induced Neurotoxicity. Neuroscience Letters, 756, Article ID: 135953. https://doi.org/10.1016/j.neulet.2021.135953
|
[5]
|
Yuan, J., Wu, Y., Li, L., et al. (2020) MicroRNA-425-5p Promotes Tau Phosphorylation and Cell Apoptosis in Alzheimer’s Disease by Targeting Heat Shock Protein B8. Journal of Neural Transmission, 127, 339-346. https://doi.org/10.1007/s00702-019-02134-5
|
[6]
|
Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved Seed Pairing, Often Flanked by Adenosines, Indicates That Thousands of Human Genes Are MicroRNA Targets. Cell, 120, 15-20. https://doi.org/10.1016/j.cell.2004.12.035
|
[7]
|
Wong, N. and Wang, X. (2015) MiRDB: An Online Resource for MicroRNA Target Prediction and Functional Annotations. Nucleic Acids Research, 43, D146-D152. https://doi.org/10.1093/nar/gku1104
|
[8]
|
Dennis Jr., G., Sherman, B.T., Hosack, D.A., et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology, 4, Article No. P3. https://doi.org/10.1186/gb-2003-4-5-p3
|
[9]
|
Szklarczyk, D., Franceschini, A., Wyder, S., et al. (2015) STRING V10: Protein-Protein Interaction Networks, Integrated over the Tree of Life. Nucleic Acids Research, 43, D447-D452. https://doi.org/10.1093/nar/gku1003
|
[10]
|
Xia, L., Zhang, F., Li, Y., et al. (2023) A New Perspective on Alzheimer’s Disease: M6A Modification. Frontiers in Genetics, 14, Article 1166831. https://doi.org/10.3389/fgene.2023.1166831
|
[11]
|
Jia, L.H. and Liu, Y.N. (2016) Downregulated Serum MiR-223 Servers as Biomarker in Alzheimer’s Disease. Cell Biochemistry and Function, 34, 233-237. https://doi.org/10.1002/cbf.3184
|
[12]
|
Liu, Q. and Lei, C. (2021) Neuroprotective Effects of MiR-331-3p through Improved Cell Viability and Inflammatory Marker Expression: Correlation of Serum MiR-331-3p Levels with Diagnosis and Severity of Alzheimer’s Disease. Cell Biochemistry and Function, 144, Article ID: 111187. https://doi.org/10.1016/j.exger.2020.111187
|
[13]
|
Zhang, M., Han, W., Xu, Y., et al. (2021) Serum MiR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease. Neuropsychiatric Disease and Treatment, 17, 269-275. https://doi.org/10.2147/NDT.S290925
|
[14]
|
Wang, R. and Zhang, J. (2020) Clinical Significance of MiR-433 in the Diagnosis of Alzheimer’s Disease and Its Effect on Aβ-Induced Neurotoxicity by Regulating JAK2. Experimental Gerontology, 141, Article ID: 111080. https://doi.org/10.1016/j.exger.2020.111080
|
[15]
|
Kang, Q., Xiang, Y., Li, D., et al. (2017) MiR-124-3p Attenuates Hyperphosphorylation of Tau Protein-Induced Apoptosis via Caveolin-1-PI3K/Akt/GSK3β Pathway in N2a/APP695swe Cells. Oncotarget, 8, 24314-24326. https://doi.org/10.18632/oncotarget.15149
|
[16]
|
Hu, G.J., Jiang, X.Y., Du, S.Y., et al. (2024) MiR-107-5p Ameliorates Neurological Damage, Oxidative Stress, and Immune Responses in Mice with Alzheimer’s Disease by Suppressing the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB(NF-κB) Pathway. The Kaohsiung Journal of Medical Sciences, 40, 119-130. https://doi.org/10.1002/kjm2.12797
|
[17]
|
Wang, H., Zeng, Z., Yi, R., et al. (2022) MicroRNA-3200-3p Targeting CAMK2A Modulates the Proliferation and Metastasis of Glioma in Vitro. Bioengineered, 13, 7785-7797. https://doi.org/10.1080/21655979.2022.2048995
|
[18]
|
Hui, K., Dong, C., Hu, C., et al. (2024) VEGFR Affects MiR-3200-3p-Mediated Regulatory T Cell Senescence in Tumour-Derived Exosomes in Non-Small Cell Lung Cancer. Functional & Integrative Genomics, 24, Article No. 31. https://doi.org/10.1007/s10142-024-01305-2
|
[19]
|
冯豆, 张洪, 范月莹, 等. MiR-3200-3p调控Wnt/β-catenin通路影响肝癌细胞的迁移和侵袭[J]. 南昌大学学报(医学版), 2022, 62(2): 14-19. https://doi.org/10.13764/j.cnki.ncdm.2022.02.003
|
[20]
|
Fang, X., Tang, W., Yang, F., et al. (2019) A Comprehensive Analysis of the CaMK2A Gene and Susceptibility to Alzheimer’s Disease in the Han Chinese Population. Frontiers in Aging Neuroscience, 11, Article 84. https://doi.org/10.3389/fnagi.2019.00084
|
[21]
|
Fessel, J. (2023) The Several Ways to Authentically Cure Alzheimer’s Dementia. Ageing Research Reviews, 92, Article ID: 102093. https://doi.org/10.1016/j.arr.2023.102093
|
[22]
|
Wang, Q., Huang, X., Su, Y., et al. (2022) Activation of Wnt/β-Catenin Pathway Mitigates Blood-Brain Barrier Dysfunction in Alzheimer’s Disease. Brain, 145, 4474-4488. https://doi.org/10.1093/brain/awac236
|
[23]
|
Xia, P., Ma, H., Chen, J., et al. (2023) Differential Expression of Pyroptosis-Related Genes in the Hippocampus of Patients with Alzheimer’s Disease. BMC Medical Genomics, 16, Article No. 56. https://doi.org/10.1186/s12920-023-01479-x
|
[24]
|
Riviere, A., Selak, M., Lantin, D., et al. (2016) Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Frontiers in Microbiology, 7, Article 979. https://doi.org/10.3389/fmicb.2016.00979
|
[25]
|
Haran, J.P., Bhattarai, S.K., Foley, S.E., et al. (2019) Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio, 10, e00632-19. https://doi.org/10.1128/mBio.00632-19
|
[26]
|
Van Bergeijk, P., Seneviratne, U., Aparicio-Prat, E., et al. (2019) SRSF1 and PTBP1 Are Trans-Acting Factors That Suppress the Formation of A CD33 Splicing Isoform Linked to Alzheimer’s Disease Risk. Molecular and Cellular Biology, 39, e00568-18. https://doi.org/10.1128/MCB.00568-18
|
[27]
|
Jakubauskiene, E., Vilys, L., Peciuliene, I., et al. (2021) The Role of Hypoxia on Alzheimer’s Disease-Related APP and Tau MRNA Formation. Gene, 766, Article ID: 145146. https://doi.org/10.1016/j.gene.2020.145146
|
[28]
|
Wang, Y.Z., Qian, Y.C., Yang, W.J., et al. (2023) CHD1 Deletion Stabilizes HIF1alpha to Promote Angiogenesis and Glycolysis in Prostate Cancer. Asian Journal of Andrology, 25, 152-157. https://doi.org/10.4103/aja202287
|
[29]
|
Potashkin, J.A., Bottero, V., Santiago, J.A., et al. (2019) Computational Identification of Key Genes That May Regulate Gene Expression Reprogramming in Alzheimer’s Patients. PLOS ONE, 14, e0222921. https://doi.org/10.1371/journal.pone.0222921
|
[30]
|
Jiang, X. and Chen, D. (2020) LncRNA FAM181A-AS1 Promotes Gliomagenesis by Sponging MiR-129-5p and Upregulating ZRANB2. Aging, 12, 20069-20084. https://doi.org/10.18632/aging.103391
|
[31]
|
Cohen, O.S., Weickert, T.W., Hess, J.L., et al. (2016) A Splicing-Regulatory Polymorphism in DRD2 Disrupts ZRANB2 Binding, Impairs Cognitive Functioning and Increases Risk for Schizophrenia in Six Han Chinese Samples. Molecular Psychiatry, 21, 975-982. https://doi.org/10.1038/mp.2015.137
|
[32]
|
Chen, F., Zhang, W., Xu, S., et al. (2023) Discovery and Validation of PURA as a Transcription Target of 20(S)-Protopanaxadiol: Implications for the Treatment of Cognitive Dysfunction. Journal of Ginseng Research, 47, 662-671. https://doi.org/10.1016/j.jgr.2023.04.007
|
[33]
|
Del Blanco, B., Ninerola, S., Martin-Gonzalez, A.M., et al. (2024) Kdm1a Safeguards the Topological Boundaries of PRC2-Repressed Genes and Prevents Aging-Related Euchromatinization in Neurons. Nature Communications, 15, Article No. 1781. https://doi.org/10.1038/s41467-024-45773-3
|
[34]
|
Karwacki-Neisius, V., Jang, A., Cukuroglu, E., et al. (2024) WNT Signalling Control by KDM5C During Development Affects Cognition. Nature, 627, 594-603. https://doi.org/10.1038/s41586-024-07067-y
|